VENTURI Trial
Phase 2
20
about 5 years
18–75
1 site in AL
What this study is about
This trial is testing a treatment for asthma. It compares two different inhaler medications to see which one works best in people with uncontrolled asthma.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI
- 2.Take Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Anti-inflammatory Agent (Corticosteroid Hormone Receptor Agonists), fluticasone furoate, Respiratory System Agent (Adrenergic beta2-Agonists), Central Nervous System Agent (Cholinergic Muscarinic Antagonists), Respiratory System Agent (Cholinergic Antagonists)
inhaled, topical (Topical Cream), oral (Oral Tablet)
Primary: Evaluate the effect of extrafine beclomethasone dipropionate/formoterol fumarate /glycopyrrolate compared with non-extrafine fluticasone furoate/ umeclidinium/vilanterol on ventilation defect percentage utilizing 129Xenon MRI.
Respiratory